Cervical cancer is the third most common lethal tumor globally, causing around a quarter million deaths annually, despite the availability of HPV vaccines. Recent Genome-wide association studies (GWAS) have identified numerous genetic markers linked to cervical cancer, including rs10175462, rs10007915, rs35721900, and rs61646675, which have been verified as being related to susceptibility to cervical cancer. However, many reports lack clarity, consistency, and validation. In this comprehensive study, we will analyze the genomic risk factors associated with cervical cancer, classify individuals into different risk categories, and explore potential biomarkers and therapeutics.
Study Type
OBSERVATIONAL
Enrollment
10,000
sequence the mutatation SNPs
The First Affiliated Hospital of USTC
Hefei, Anhui, China
RECRUITINGEvalutaiton of the SNPs test in an average cervical cancer patients screening episode
Time frame: two years
Classified susceptied person into different ladders
Time frame: two years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.